PMS-CONJUGATED ESTROGENS C.S.D. DIN 00587281
Health Canada record
| Active ingredient(s) | CONJUGATED ESTROGENS 0.625 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03CA57 CONJUGATED ESTROGENS |
| Original market date | 31-Dec-1983 |
| Current status date | 30-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CONJUGATED ESTROGENS
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02432854 | DUAVIVE | PFIZER CANADA ULC | Tablet (Immediate- And Extended-Release) | CONJUGATED ESTROGENS 0.45 MG; BAZEDOXIFENE (BAZEDOXIFENE ACETATE) 20 MG | Marketed |
| 02414678 | PREMARIN | PFIZER CANADA ULC | Tablet (Extended-Release) | CONJUGATED ESTROGENS 0.3 MG | Marketed |
| 02414694 | PREMARIN | PFIZER CANADA ULC | Tablet (Extended-Release) | CONJUGATED ESTROGENS 1.25 MG | Marketed |
| 02414686 | PREMARIN | PFIZER CANADA ULC | Tablet (Extended-Release) | CONJUGATED ESTROGENS 0.625 MG | Marketed |
| 02043386 | PREMARIN INTRAVENOUS | PFIZER CANADA ULC | Powder For Solution | CONJUGATED ESTROGENS 25 MG | Marketed |
| 02043440 | PREMARIN VAGINAL CREAM | PFIZER CANADA ULC | Cream | CONJUGATED ESTROGENS 0.625 MG | Marketed |
| 00798231 | APO-CONEST TAB 0.3MG | APOTEX INC | Tablet | CONJUGATED ESTROGENS 0.3 MG | Cancelled Post Market |
| 00798223 | APO-CONEST TAB 0.625MG | APOTEX INC | Tablet | CONJUGATED ESTROGENS 0.625 MG | Cancelled Post Market |
| 00798215 | APO-CONEST TAB 0.9MG | APOTEX INC | Tablet | CONJUGATED ESTROGENS 0.9 MG | Cancelled Post Market |
| 00798207 | APO-CONEST TAB 1.25MG | APOTEX INC | Tablet | CONJUGATED ESTROGENS 1.25 MG | Cancelled Post Market |
| 00798193 | APO-CONEST TAB 2.5MG | APOTEX INC | Tablet | CONJUGATED ESTROGENS 2.5 MG | Cancelled Post Market |
| 00265470 | C.E.S. | BAUSCH HEALTH, CANADA INC. | Tablet | CONJUGATED ESTROGENS 0.625 MG | Dormant |
| 02230892 | C.E.S. TABLETS | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | CONJUGATED ESTROGENS 0.9 MG | Cancelled Post Market |
| 00265489 | C.E.S. TABLETS | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | CONJUGATED ESTROGENS 1.25 MG | Cancelled Post Market |
| 02230891 | C.E.S. TABLETS | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | CONJUGATED ESTROGENS 0.3 MG | Cancelled Post Market |
| 00830216 | CONGEST | LABORATOIRE RIVA INC. | Tablet | CONJUGATED ESTROGENS 1.25 MG | Dormant |
| 00830208 | CONGEST | LABORATOIRE RIVA INC. | Tablet | CONJUGATED ESTROGENS 2.5 MG | Dormant |
| 00830224 | CONGEST | LABORATOIRE RIVA INC. | Tablet | CONJUGATED ESTROGENS 0.9 MG | Dormant |
| 00830232 | CONGEST | LABORATOIRE RIVA INC. | Tablet | CONJUGATED ESTROGENS 0.625 MG | Dormant |
| 00830240 | CONGEST | LABORATOIRE RIVA INC. | Tablet | CONJUGATED ESTROGENS 0.3 MG | Dormant |
| 02239655 | PMS-CONJUGATED ESTROGENS C.S.D. | PHARMASCIENCE INC | Tablet | CONJUGATED ESTROGENS 0.9 MG | Cancelled Post Market |
| 02239654 | PMS-CONJUGATED ESTROGENS C.S.D. | PHARMASCIENCE INC | Tablet | CONJUGATED ESTROGENS 0.3 MG | Cancelled Post Market |
| 00587303 | PMS-CONJUGATED ESTROGENS C.S.D. | PHARMASCIENCE INC | Tablet | CONJUGATED ESTROGENS 1.25 MG | Cancelled Post Market |
| 02043408 | PREMARIN | PFIZER CANADA ULC | Tablet | CONJUGATED ESTROGENS 0.625 MG | Cancelled Post Market |
| 02043394 | PREMARIN | PFIZER CANADA ULC | Tablet | CONJUGATED ESTROGENS 0.3 MG | Cancelled Post Market |
| 02043424 | PREMARIN | PFIZER CANADA ULC | Tablet | CONJUGATED ESTROGENS 1.25 MG | Cancelled Post Market |
| 00002283 | PREMARIN INJ 25MG/5ML | AYERST LABORATORIES | Powder For Solution | CONJUGATED ESTROGENS 25 MG | Cancelled Post Market |
| 00002569 | PREMARIN TABLETS 0.3MG | AYERST LABORATORIES | Tablet | CONJUGATED ESTROGENS 0.3 MG | Cancelled Post Market |
| 00002577 | PREMARIN TABLETS 0.625MG | AYERST LABORATORIES | Tablet | CONJUGATED ESTROGENS 0.625 MG | Cancelled Post Market |
| 02043416 | PREMARIN TABLETS 0.9MG | WYETH CANADA | Tablet | CONJUGATED ESTROGENS 0.9 MG | Cancelled Post Market |
| 00002585 | PREMARIN TABLETS 1.25MG | AYERST LABORATORIES | Tablet | CONJUGATED ESTROGENS 1.25 MG | Cancelled Post Market |
| 02043432 | PREMARIN TABLETS 2.5MG | WYETH-AYERST CANADA INC. | Tablet | CONJUGATED ESTROGENS 2.5 MG | Cancelled Post Market |
| 00002593 | PREMARIN TABLETS 2.5MG | AYERST LABORATORIES | Tablet | CONJUGATED ESTROGENS 2.5 MG | Cancelled Post Market |
| 02242879 | PREMPLUS | PFIZER CANADA ULC | Tablet; Kit | CONJUGATED ESTROGENS 0.625 MG; MEDROXYPROGESTERONE ACETATE 5 MG | Cancelled Post Market |
| 02242878 | PREMPLUS | PFIZER CANADA ULC | Tablet; Kit | CONJUGATED ESTROGENS 0.625 MG; MEDROXYPROGESTERONE ACETATE 2.5 MG | Cancelled Post Market |
| 02242880 | PREMPLUS CYCLE | PFIZER CANADA ULC | Kit; Tablet | CONJUGATED ESTROGENS 0.625 MG; MEDROXYPROGESTERONE ACETATE 10 MG | Cancelled Pre Market |
International API supply for CONJUGATED ESTROGENS
3 active FDA Drug Master Files.
Request a quote for PMS-CONJUGATED ESTROGENS C.S.D.